Literature DB >> 2153017

Adenovirus hepatitis in two successive liver transplants in a child.

N M Varki1, S Bhuta, T Drake, D D Porter.   

Abstract

Adenoviruses can produce severe disease, especially in patients who are immunosuppressed. We present a unique case in which adenovirus type 5 was demonstrated retrospectively, by using immunohistochemical methods, in the appendix of a liver transplant donor. The donor had intussusception, which has been associated with adenovirus infection. Both the initial and a second liver transplant in the recipient were severely damaged by adenovirus type 5. These findings were demonstrated immunohistochemically, as well as on electron microscopy. The recipient died due to the infection and ensuing complications.

Entities:  

Mesh:

Year:  1990        PMID: 2153017

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  6 in total

1.  Adenovirus infection in pediatric liver transplant recipients.

Authors:  M G Michaels; M Green; E R Wald; T E Starzl
Journal:  J Infect Dis       Date:  1992-01       Impact factor: 5.226

Review 2.  Current status of human adenovirus infection in China.

Authors:  Nai-Ying Mao; Zhen Zhu; Yan Zhang; Wen-Bo Xu
Journal:  World J Pediatr       Date:  2022-06-18       Impact factor: 9.186

3.  Adenovirus infection of the large bowel in HIV positive patients.

Authors:  A Maddox; N Francis; J Moss; C Blanshard; B Gazzard
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

Review 4.  Adenoviruses in the immunocompromised host.

Authors:  J C Hierholzer
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

Review 5.  Neuropathologic findings after liver transplantation.

Authors:  J A Ferreiro; M A Robert; J Townsend; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 6.  Fulminant hepatitis due to human adenovirus.

Authors:  B A Ronan; N Agrwal; E J Carey; G De Petris; S Kusne; M T Seville; J E Blair; H R Vikram
Journal:  Infection       Date:  2013-08-24       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.